Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
290 employees
New York Genome Center, Inc.: A noncommercial research organization, founded in 2010 in New York, US.
HQ
Founded
2010
Founded in 2010, the New York Genome Center (NYGC) is a noncommercial research organization based in New York City. Its core mission is to advance genomics research and its application to improve human health. NYGC focuses on basic, clinical, and translational research in genomics, bioinformatics, DNA sequencing, and whole genome sequencing. The center collaborates with various academic and medical institutions to drive innovation in genomic science.
Notable figures associated with NYGC include Tom Maniatis, PhD, who serves as the Evnin Family Scientific Director and CEO. The center has affiliations with prestigious institutions such as the American Museum of Natural History, Cold Spring Harbor Laboratory, Columbia University, and Albert Einstein College of Medicine. Key achievements include significant contributions to genomic research and advancements in personalized medicine. NYGC's impact is evident in its role as a leading hub for genomic science, fostering collaboration and innovation in the field.
Operating Status
Active
Ownership Type(s)
Non-profit
Main Product(s)
Genomics Research
Technology
Genomics, Bioinformatics
Tags
Biotech, Data
Model Types
Non-Profit
Revenue Type(s)
United States
When was New York Genome Center founded?
New York Genome Center was founded in 2010.
Where is New York Genome Center's headquarters located?
New York Genome Center's headquarters is located in New York City, NY, US.
When was New York Genome Center's last funding round?
New York Genome Center's most recent funding round was for $125M (USD) in May 2019.
How many employees does New York Genome Center have?
New York Genome Center has 290 employees as of Feb 4, 2024.
How much has New York Genome Center raised to-date?
As of July 05, 2023, New York Genome Center has raised a total of $131M (USD) since May 23, 2019.
Add Comparison
Total Raised to Date
$131M
USD
Last Update May 23, 2019
Last Deal Details
$125M
USD
May 23, 2019
Grant
Current Employees
290
Last updated: Feb 4, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts